Výsledky vyhledávání - "David H Henry"

Akademický článek

Systemically circulating viral and tumor-derived microRNAs in KSHV-associated malignancies.

Autor: Pauline E Chugh, Sang-Hoon Sin, Sezgin Ozgur, David H Henry, Prema Menezes, Jack Griffith, Joseph J Eron, Blossom Damania, Dirk P Dittmer

Publikováno v: PLoS Pathogens, Vol 9, Iss 7, p e1003484 (2013)

MicroRNAs (miRNAs) are stable, small non-coding RNAs that modulate many downstream target genes. Recently, circulating miRNAs have been detected in various body fluids and within exosomes, prompting their evaluation as candidate biomarkers of disease

Externí odkaz: https://doaj.org/article/b16e1b81183045c0b0f5e83a301ce1a8

Zobrazit plný text záznamu

Akademický článek

Risk factors associated with skeletal-related events following discontinuation of denosumab treatment among patients with bone metastases from solid tumors: A real-world machine learning approach

Autor: Dionna Jacobson, Benoit Cadieux, Celestia S. Higano, David H. Henry, Basia A. Bachmann, Marko Rehn, Alison T. Stopeck, Hossam Saad

Publikováno v: Journal of Bone Oncology, Vol 34, Iss , Pp 100423- (2022)

Background: Clinical practice guidelines recommend the use of bone-targeting agents for preventing skeletal-related events (SREs) among patients with bone metastases from solid tumors. The anti-RANKL monoclonal antibody denosumab is approved for the

Externí odkaz: https://doaj.org/article/d9d83d9457b64c0bb7e80b98fa064670

Zobrazit plný text záznamu

Akademický článek

A retrospective analysis of venous thromboembolism trends in chemotherapy‐induced anemia: Red blood cell transfusion versus erythrocyte stimulating agent administration

Autor: Emily J. Bryer, Michael J. Kallan, Ting‐Shan Chiu, Katharina M. Scheuba, David H. Henry

Publikováno v: eJHaem, Vol 1, Iss 1, Pp 35-43 (2020)

Abstract Background Patients receiving a variety of chemotherapy regimens often develop chemotherapy‐induced anemia (CIA), which contributes to poor outcomes including increased mortality. Prompt and effective treatment of CIA is essential to preve

Externí odkaz: https://doaj.org/article/566f5901ecce4c0eb191868869373164

Zobrazit plný text záznamu

Akademický článek

Response-adapted therapy with infusional EPOCH chemotherapy plus rituximab in HIV-associated, B-cell non-Hodgkin's lymphoma

Autor: Joseph A. Sparano, Jeannette Y. Lee, Lawrence D. Kaplan, Juan Carlos Ramos, Richard F. Ambinder, William Wachsman, David Aboulafia, Ariela Noy, David H. Henry, Lee Ratner, Ethel Cesarman, Amy Chadburn, Ronald Mitsuyasu

Publikováno v: Haematologica, Vol 106, Iss 3 (2020)

Four cycles of rituximab plus CHOP chemotherapy is as effective as 6 cycles in low-risk diffuse large B-cell lymphoma (DLBCL). Here we report a post-hoc analysis of a prospective clinical trial in patients with HIV-associated DLBCL and high-grade lym

Externí odkaz: https://doaj.org/article/078d20628e604f39b442cee01904788e

Zobrazit plný text záznamu

Intravenous ferric derisomaltose for the treatment of iron deficiency anemia

Autor: Thomas G. DeLoughery, David H. Henry, Michael Auerbach

Publikováno v: American Journal of Hematology

Intravenous (IV) iron is the therapy of choice when oral iron is ineffective or poorly tolerated, yet use has been limited by fears of hypersensitivity reactions (HSRs). Newer formulations that bind iron more tightly and release it more slowly have m

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd95a76d8e4c64da3bf6a4f1d1f5ae85
https://doi.org/10.1002/ajh.26124

Zobrazit plný text záznamu

A retrospective analysis of venous thromboembolism trends in chemotherapy‐induced anemia: Red blood cell transfusion versus erythrocyte stimulating agent administration

Autor: Ting-Shan Chiu, Katharina M. Scheuba, Michael J. Kallan, Emily Bryer, David H. Henry

Publikováno v: eJHaem. 1:35-43

Patients receiving a variety of chemotherapy regimens often develop chemotherapy-induced anemia (CIA), which contributes to poor outcomes including increased mortality. Prompt and effective treatment of CIA is essential to prevent fewer chemotherapy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06a0bb9cee0dfed0404c4d959535c1cf
https://doi.org/10.1002/jha2.18

Zobrazit plný text záznamu

Response-adapted therapy with infusional EPOCH chemotherapy plus rituximab in HIV-associated, B-cell non-Hodgkin's lymphoma

Autor: Ethel Cesarman, Jeannette Y. Lee, Joseph A. Sparano, Juan Carlos Ramos, Ronald T. Mitsuyasu, Ariela Noy, William Wachsman, Amy Chadburn, David H. Henry, Richard F. Ambinder, Lawrence D. Kaplan, Lee Ratner, David M. Aboulafia

Publikováno v: Haematologica. 106:730-735

Introduction: Six cycles of rituximab plus infusional EPOCH is considered a preferred regimen for first-line treatment of HIV-associated diffuse large B-cell lymphoma (DLBCL), HHV8-positive DLBCL, and primary effusion lymphoma, and is among the prefe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1ccfd7428e208175c04d7633da58616
https://doi.org/10.3324/haematol.2019.243386

Zobrazit plný text záznamu

Risk factors associated with skeletal-related events following discontinuation of denosumab treatment among patients with bone metastases from solid tumors: A real-world machine learning approach

Autor: Dionna Jacobson, Benoit Cadieux, Celestia S. Higano, David H. Henry, Basia A. Bachmann, Marko Rehn, Alison T. Stopeck, Hossam Saad

Publikováno v: Journal of bone oncology. 34

Clinical practice guidelines recommend the use of bone-targeting agents for preventing skeletal-related events (SREs) among patients with bone metastases from solid tumors. The anti-RANKL monoclonal antibody denosumab is approved for the prevention o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::487364857cdf6c3e3de5c76cc7e87dff
https://pubmed.ncbi.nlm.nih.gov/35378840

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání